Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers

British Journal of Clinical Pharmacology
P J CadiganP L Morselli

Abstract

1 The effects of betaxolol (SL 75212), a new beta-adrenoceptor blocking agent, on the cardiovascular response to exercise have been studied in six normal subjects after placebo and single oral doses of 5, 10, 20 and 40 mg given double-blind in a randomized sequence. 2 All doses reduced exercise heart rate, with a significant reduction persisting to 23 h after doses of 20 mg and 40 mg. Systolic blood pressure on exercise was reduced after all doses, with a reduction continuing to 23 h after doses of 10 mg and above. 3 The mean elimination half-life of SL 75212 was 17.5 +/- 3.9 h. The plasma clearance ranged from 0.15--0.48 1 kg-1 h-1 and the volume of distribution from 5.8--13 1 kg-1. 4 There was a significant correlation between the peak blood levels and change in exercise heart rate (r = 0.53, P less than 0.05) and between the area under the blood concentration curve and the effect of the exercise heart rate (r = 0.55, P less than 0.01).

References

May 1, 1977·Journal of Clinical Pharmacology·J DreyfussD A Willard
Jun 1, 1979·British Journal of Clinical Pharmacology·R D Watson, W A Littler
Mar 1, 1979·Clinical Pharmacokinetics·P A Routledge, D G Shand
Mar 1, 1979·British Journal of Clinical Pharmacology·G L JenningsP I Korner
Jun 1, 1979·British Journal of Clinical Pharmacology·S H WanR F Maronde
May 1, 1974·Clinical Pharmacology and Therapeutics·S G CarruthersR G Shanks
Apr 1, 1974·British Journal of Clinical Pharmacology·S G CarruthersR G Shanks

❮ Previous
Next ❯

Citations

Jan 1, 1986·European Journal of Clinical Pharmacology·G BianchettiJ P Thenot
Jul 5, 2001·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·E Vainio-JylhäR Huupponen
Jul 1, 1990·British Journal of Clinical Pharmacology·N A IrvineD G McDevitt
Feb 1, 1991·British Journal of Clinical Pharmacology·B J LipworthD G McDevitt
Jan 1, 1984·American Journal of Ophthalmology·R B SchoeneC H Beasley
Dec 15, 1985·American Journal of Ophthalmology·J G Feghali, P L Kaufman
Jan 1, 1983·European Journal of Clinical Pharmacology·R Palminteri, G Kaik
May 1, 1987·Australian and New Zealand Journal of Ophthalmology·A M BrooksR H West
Aug 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J H BauerA Lau
Nov 1, 1989·Australian and New Zealand Journal of Ophthalmology·A M BrooksW E Gillies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.